Safety and immunogenicity of DTaP5-IPV compared with DTaP5 plus IPV as the fifth dose in children 4–6 years of age

MJ Smith, E Jordanov, X Sheng… - The Pediatric Infectious …, 2017 - journals.lww.com
Background: Immunogenicity and safety of stand-alone diphtheria, tetanus toxoid, 5-
component acellular pertussis vaccine adsorbed, inactivated poliovirus (IPV) combination …

Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP–IPV) compared to separate administration …

SY Lee, HS Hwang, JH Kim, HH Kim, HS Lee… - Vaccine, 2011 - Elsevier
This randomized trial enrolled 442 infants in the Republic of Korea to assess the
immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and …

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4–6 years of age

S Black, LR Friedland, K Ensor… - The Pediatric …, 2008 - journals.lww.com
Background: In the United States, diphtheria-tetanus-acellular pertussis (DTaP) and
inactivated poliovirus (IPV) booster vaccinations are recommended for children 4–6 years of …

Kinrix™: a new combination DTaP–IPV vaccine for children aged 4–6 years

WM Weston, NP Klein - Expert Review of Vaccines, 2008 - Taylor & Francis
Combination vaccines allow the administration of multiple vaccine antigens without the need
for multiple injections. Recently, a combined diphtheria toxoid, tetanus toxoid, acellular …

DTaP-IPV/Hib vaccine (Pentacel®)

S Dhillon, SJ Keam - Pediatric Drugs, 2008 - Springer
Abstract▲ The combination vaccine diphtheria and tetanus toxoids and acellular pertussis
adsorbed, inactivated poliovirus and Haemophilus b conjugate (tetanus toxoid conjugate) …

[HTML][HTML] Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine …

SM Lee, SJ Kim, J Chen, JH Kim… - Human Vaccines & …, 2019 - Taylor & Francis
ABSTRACT Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …

Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular …

T Vesikari, SA Silfverdal, F Boisnard… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
This study compared the levels of immunogenicity and safety of diphtheria–tetanus toxoid–
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …

Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus …

SA Halperin, B Tapiéro, M Dionne… - The Pediatric …, 2014 - journals.lww.com
Background: Combination diphtheria-tetanus-5 component acellular pertussis-inactivated
poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (DTaP 5-IPV-Hib-HepB) …

[HTML][HTML] Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose

J Liang, G Wallace, G Mootrey - MMWR Morb Mortal Wkly Rep, 2015 - cdc.gov
On March 24, 2015, the Food and Drug Administration licensed an additional combined
diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated …

A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience

C Huoi, J Vargas-Zambrano, D Macina… - Expert Review of …, 2022 - Taylor & Francis
Introduction Routine infant primary series and toddler booster vaccination are associated
with waning of antibody levels over time, which can lead to an increased incidence of …